Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 3
2022 3
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Intratumoral Heterogeneity of Molecular Subtypes in Muscle-invasive Bladder Cancer-An Extensive Multiregional Immunohistochemical Analysis.
Schallenberg S, Dragomir MP, Anders P, Ebner B, Volz Y, Eismann L, Rodler S, Casuscelli J, Buchner A, Klauschen F, Stief C, Horst D, Schulz GB. Schallenberg S, et al. Among authors: anders p. Eur Urol Focus. 2023 Sep;9(5):788-798. doi: 10.1016/j.euf.2023.03.012. Epub 2023 Apr 17. Eur Urol Focus. 2023. PMID: 37076398
Systematic review of prognostic factors associated with progression to late age-related macular degeneration: Pinnacle study report 2.
Hagag AM, Kaye R, Hoang V, Riedl S, Anders P, Stuart B, Traber G, Appenzeller-Herzog C, Schmidt-Erfurth U, Bogunovic H, Scholl HP, Prevost T, Fritsche L, Rueckert D, Sivaprasad S, Lotery AJ. Hagag AM, et al. Among authors: anders p. Surv Ophthalmol. 2024 Mar-Apr;69(2):165-172. doi: 10.1016/j.survophthal.2023.10.010. Epub 2023 Oct 27. Surv Ophthalmol. 2024. PMID: 37890677 Free article. Review.
The Optical Coherence Tomography and Microperimetry Biomarker Evaluation in Patients with Geographic Atrophy (OMEGA) Study: Design and Baseline Characteristics - OMEGA Report 1.
Ansari G, Schärer N, Camenzind Zuche H, Gabrani C, Anders P, Pfau K, Valmaggia P, Giani A, Esmaeelpour M, Chingning Yamaguchi T, Prünte CF, Maloca PM, Schmetterer L, Scholl HPN, Pfau M. Ansari G, et al. Among authors: anders p. Ophthalmic Res. 2023;66(1):1392-1401. doi: 10.1159/000535375. Epub 2023 Nov 28. Ophthalmic Res. 2023. PMID: 38016431 Free article.
Developing and validating a multivariable prediction model which predicts progression of intermediate to late age-related macular degeneration-the PINNACLE trial protocol.
Sutton J, Menten MJ, Riedl S, Bogunović H, Leingang O, Anders P, Hagag AM, Waldstein S, Wilson A, Cree AJ, Traber G, Fritsche LG, Scholl H, Rueckert D, Schmidt-Erfurth U, Sivaprasad S, Prevost T, Lotery A. Sutton J, et al. Among authors: anders p. Eye (Lond). 2023 Apr;37(6):1275-1283. doi: 10.1038/s41433-022-02097-0. Epub 2022 May 25. Eye (Lond). 2023. PMID: 35614343 Free PMC article.
TTF-1 status in early-stage lung adenocarcinoma is an independent predictor of relapse and survival superior to tumor grading.
Schallenberg S, Dernbach G, Dragomir MP, Schlachtenberger G, Boschung K, Friedrich C, Standvoss K, Ruff L, Anders P, Grohé C, Randerath W, Merkelbach-Bruse S, Quaas A, Heldwein M, Keilholz U, Hekmat JK, Rückert C, Büttner R, Horst D, Klauschen F, Frost N. Schallenberg S, et al. Among authors: anders p. Eur J Cancer. 2024 Jan;197:113474. doi: 10.1016/j.ejca.2023.113474. Epub 2023 Dec 10. Eur J Cancer. 2024. PMID: 38100920 Free article.
12 results